8 Stocks Jim Cramer Discussed & Mentioned An Important Quantum Computing Development

2. Amgen Inc. (NASDAQ:AMGN)

Number of Hedge Fund Holders In Q2 2025: 62

Cramer has recently started to discuss pharmaceutical giant Amgen Inc. (NASDAQ:AMGN) more frequently. Most of his discussions surround the firm’s Repatha drug that aims to reduce cholesterol and prevent adverse cardiovascular events. In a November 11th appearance, the CNBC TV host commented that Amgen Inc. (NASDAQ:AMGN), along with JNJ, could be a stock worth owning. He added that the firm might also be working on a novel approach for the weight loss drug market. In this appearance, he commented that money was finally flowing into healthcare stocks such as Amgen Inc. (NASDAQ:AMGN):

“If you take a look at a stock like Amgen, Rob Bradway, the CEO, they’ve got a new, really good data about lowering cholesterol, much lower with Repatha and it’s going to be part of the TrumpRx. And this is what they’re going to. Now do I buy the parabolic move? No. But you need to realize that the money staying in the market, it’s just going to places it hasn’t been to in a long time.”